Reuters
WASHINGTON, Feb 8 (Reuters) - US drug reviewers questioned effectiveness data from Cell Therapeutics Inc (CTIC.O) for an experimental lymphoma drug and said the medicine carried substantial side effects, according to documents released ...
FDA: Limited Clinical Data On Proposed Cancer Drug PixantroneWall Street Journal
BioMarin, Cell Therapeutics lead drug stocks southMarketWatch
FDA Raises Concerns About Cell Therapeutics Cancer DrugTheStreet.com
Xconomy -RTT News
all 12 news articles »